Literature DB >> 10336105

Longitudinal patterns of tobacco smoking from childhood to middle age.

H Janson1.   

Abstract

This study described the development of tobacco smoking of subjects between ages 12 and 36 using prospectively collected self-reports of 212 Swedish men and women born in the 1950s. Smoking habits were studied in terms of stability, longitudinal patterns of smoking, and the relation between age of initiation and later smoking. Findings showed that light smoking (up to 6 cigarettes/day) did not remain stable after adolescence. Typical development patterns from age 15 to age 36 included staying a nonsmoker; smoking intensely (>10 cigarettes/day) and continuing into adulthood; smoking less intensely for some periods; or smoking intensely and quitting before age 36. Differences in age at smoking initiation were related to later habitual smoking only when participants reported initiation had occurred after age 12.

Entities:  

Mesh:

Year:  1999        PMID: 10336105     DOI: 10.1016/s0306-4603(98)00061-6

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  10 in total

1.  How should we define light or intermittent smoking? Does it matter?

Authors:  Corinne G Husten
Journal:  Nicotine Tob Res       Date:  2009-02-20       Impact factor: 4.244

2.  Adolescence is a period of development characterized by short- and long-term vulnerability to the rewarding effects of nicotine and reduced sensitivity to the anorectic effects of this drug.

Authors:  Luis A Natividad; Oscar V Torres; Theodore C Friedman; Laura E O'Dell
Journal:  Behav Brain Res       Date:  2013-10-10       Impact factor: 3.332

3.  Perspective: A Critical Look at the Ancillary Age-Related Eye Disease Study 2: Nutrition and Cognitive Function Results in Older Individuals with Age-Related Macular Degeneration.

Authors:  Billy R Hammond; Lisa M Renzi-Hammond
Journal:  Adv Nutr       Date:  2016-05-16       Impact factor: 8.701

4.  Conduct disorder and initiation of substance use: a prospective longitudinal study.

Authors:  Christian Hopfer; Stacy Salomonsen-Sautel; Susan Mikulich-Gilbertson; Sung-Joon Min; Matt McQueen; Thomas Crowley; Susan Young; Robin Corley; Joseph Sakai; Christian Thurstone; Analice Hoffenberg; Christie Hartman; John Hewitt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-04-04       Impact factor: 8.829

5.  Do Mexican immigrants "import" social gradients in health to the US?

Authors:  Alison Buttenheim; Noreen Goldman; Anne R Pebley; Rebeca Wong; Chang Chung
Journal:  Soc Sci Med       Date:  2010-07-13       Impact factor: 4.634

6.  Factors underlying prefrontal and insula structural alterations in smokers.

Authors:  Xiaochu Zhang; Betty Jo Salmeron; Thomas J Ross; Xiujuan Geng; Yihong Yang; Elliot A Stein
Journal:  Neuroimage       Date:  2010-08-10       Impact factor: 6.556

7.  Estimation of Transitional Probabilities of Discrete Event Systems from Cross-Sectional Survey and its Application in Tobacco Control.

Authors:  Feng Lin; Xinguang Chen
Journal:  Inf Sci (N Y)       Date:  2010-02-01       Impact factor: 6.795

8.  Level of cigarette consumption and quit behavior in a population of low-intensity smokers--longitudinal results from the International Tobacco Control (ITC) survey in Mexico.

Authors:  Kamala Swayampakala; James Thrasher; Matthew J Carpenter; Luz Myriam Reynales Shigematsu; Ana-Paula Cupertio; Carla J Berg
Journal:  Addict Behav       Date:  2012-12-16       Impact factor: 3.913

Review 9.  Early-onset drug use and risk for drug dependence problems.

Authors:  Chuan-Yu Chen; Carla L Storr; James C Anthony
Journal:  Addict Behav       Date:  2008-11-01       Impact factor: 3.913

10.  Increased thalamic volume and decreased thalamo-precuneus functional connectivity are associated with smoking relapse.

Authors:  Chao Wang; Shuyue Wang; Zhujing Shen; Wei Qian; Yeerfan Jiaerken; Xiao Luo; Kaicheng Li; Qingze Zeng; Quanquan Gu; Yihong Yang; Peiyu Huang; Minming Zhang
Journal:  Neuroimage Clin       Date:  2020-09-28       Impact factor: 4.881

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.